Loading...
Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations
Dihydroergotamine (DHE) is an ergot alkaloid derivative of substances produced by rye fungus. Ergotamine was first used in the field of gynecology and obstetrics, then used for migraine treatment a few years later. DHE was developed as a derivative of ergotamine. DHE, when compared to ergotamine, de...
Na minha lista:
| Udgivet i: | J Pain Res |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7200221/ https://ncbi.nlm.nih.gov/pubmed/32431533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S203650 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|